{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:54:26Z","timestamp":1782784466810,"version":"3.54.5"},"reference-count":98,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Focusing on the current state of the art, this article (a) describes recent advances in the understanding of the pathogenesis of venous thromboembolism (VTE), (b) discusses current approaches for the prevention, diagnosis and treatment of VTE, (c) outlines the role of aspirin for VTE prevention and treatment, and (d) highlights the unmet needs in VTE management and describes novel approaches to address them.<\/ns4:p>","DOI":"10.12688\/f1000research.27115.1","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T15:10:06Z","timestamp":1601997006000},"page":"1206","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Recent advances in understanding, diagnosing and treating venous thrombosis"],"prefix":"10.12688","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9491-6172","authenticated-orcid":false,"given":"Noel C","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1092-7550","authenticated-orcid":false,"given":"Jeffrey I","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"I4-8","DOI":"10.1161\/01.CIR.0000078468.11849.66","article-title":"The epidemiology of venous thromboembolism.","volume":"107","author":"R White","year":"2003","journal-title":"Circulation."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"445-53","DOI":"10.1001\/archinte.159.5.445","article-title":"Predictors of survival after deep vein thrombosis and pulmonary embolism: A population-based, cohort study.","volume":"159","author":"J Heit","year":"1999","journal-title":"Arch Intern Med."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"1-7","DOI":"10.7326\/0003-4819-125-1-199607010-00001","article-title":"The long-term clinical course of acute deep venous thrombosis.","volume":"125","author":"P Prandoni","year":"1996","journal-title":"Ann Intern Med."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"698-707","DOI":"10.7326\/0003-4819-149-10-200811180-00004","article-title":"Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis.","volume":"149","author":"S Kahn","year":"2008","journal-title":"Ann Intern Med."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"1601792","DOI":"10.1183\/13993003.01792-2016","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: A contemporary view of the published literature.","volume":"49","author":"Y Ende-Verhaar","year":"2017","journal-title":"Eur Respir J."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"109-14","DOI":"10.1182\/blood-2016-12-758995","article-title":"Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US.","volume":"130","author":"J Heit","year":"2017","journal-title":"Blood."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"1409-24","DOI":"10.1161\/CIRCRESAHA.116.306925","article-title":"Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants.","volume":"118","author":"N Chan","year":"2016","journal-title":"Circ Res."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"237-41","DOI":"10.1182\/asheducation-2017.1.237","article-title":"Symptomatic subsegmental pulmonary embolism: To treat or not to treat?","volume":"2017","author":"M Carrier","year":"2017","journal-title":"Hematology."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"2035-41","DOI":"10.1111\/j.1538-7836.2009.03635.x","article-title":"Safety and sensitivity of two ultrasound strategies in patients with clinically suspected deep venous thrombosis: A prospective management study.","volume":"7","author":"N Gibson","year":"2009","journal-title":"J Thromb Haemost."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"351-9","DOI":"10.1182\/blood.2019000919","article-title":"Novel antithrombotic strategies for treatment of venous thromboembolism.","volume":"135","author":"J Weitz","year":"2020","journal-title":"Blood."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"2131-8","DOI":"10.1001\/archinte.1988.00380100029007","article-title":"Calf deep venous thrombosis. A wolf in sheep's clothing?","volume":"148","author":"J Philbrick","year":"1988","journal-title":"Arch Intern Med."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"517-28","DOI":"10.1136\/jcp.27.7.517","article-title":"The structure and growth of valve-pocket thrombi in femoral veins.","volume":"27","author":"S Sevitt","year":"1974","journal-title":"J Clin Pathol."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"563-8","DOI":"10.1161\/ATVBAHA.111.242818","article-title":"Mechanistic View of Risk Factors for Venous Thromboembolism.","volume":"32","author":"P Reitsma","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"225-9","DOI":"10.1016\/j.blre.2009.07.002","article-title":"Basic mechanisms and pathogenesis of venous thrombosis.","volume":"23","author":"C Esmon","year":"2009","journal-title":"Blood Rev."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"1222-31","DOI":"10.1056\/NEJM200104193441607","article-title":"Genetic Susceptibility to Venous Thrombosis.","volume":"344","author":"U Seligsohn","year":"2001","journal-title":"N Engl J Med."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"1004-8","DOI":"10.1073\/pnas.90.3.1004","article-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C.","volume":"90","author":"B Dahlb\u00e4ck","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"3698-703","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.","volume":"88","author":"S Poort,","year":"1996","journal-title":"Blood."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"1177-87","DOI":"10.1056\/NEJMra1700365","article-title":"Thrombophilia Testing and Venous Thrombosis.","volume":"377","author":"J Connors","year":"2017","journal-title":"N Engl J Med."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"I9-16","DOI":"10.1161\/01.CIR.0000078469.07362.E6","article-title":"Risk factors for venous thromboembolism.","volume":"107","author":"F Anderson","year":"2003","journal-title":"Circulation."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"678-85","DOI":"10.1097\/00000658-196010000-00011","article-title":"Venous Stasis in the Lower Extremities.","volume":"152","author":"A McLachlin","year":"1960","journal-title":"Ann Surg."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"166-70","DOI":"10.1002\/bjs.1800680308","article-title":"The PO2 in venous valve pockets: Its possible bearing on thrombogenesis.","volume":"68","author":"J Hamer","year":"1981","journal-title":"Br J Surg."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"1276-9","DOI":"10.1182\/blood-2009-03-209981","article-title":"Valves of the deep venous system: An overlooked risk factor.","volume":"114","author":"E Brooks","year":"2009","journal-title":"Blood."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"5489-500","DOI":"10.1172\/JCI124791","article-title":"Hemodynamic regulation of perivalvular endothelial gene expression prevents deep venous thrombosis.","volume":"129","author":"J Welsh","year":"2019","journal-title":"J Clin Invest."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"1874-80","DOI":"10.1161\/01.cir.0000031705.57473.1c","article-title":"Upper-extremity deep vein thrombosis.","volume":"106","author":"H Joffe","year":"2002","journal-title":"Circulation."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"515-25","DOI":"10.1146\/annurev-physiol-042210-121137","article-title":"Role of Tissue Factor in Venous Thrombosis.","volume":"73","author":"D Manly","year":"2011","journal-title":"Annu Rev Physiol."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"459-66","DOI":"10.1160\/TH04-05-0306","article-title":"Role of P-selectin and PSGL-1 in coagulation and thrombosis.","volume":"92","author":"E Vandendries","year":"2004","journal-title":"Thromb Haemost."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"343-51","DOI":"10.1160\/TH07-10-0608","article-title":"Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation.","volume":"99","author":"T Meier","year":"2017","journal-title":"Thromb Haemost."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"558-68","DOI":"10.1172\/JCI58969","article-title":"Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin.","volume":"122","author":"A Owens","year":"2012","journal-title":"J Clin Invest."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"422-30","DOI":"10.1016\/j.thromres.2011.05.012","article-title":"Statins in the prevention of venous thromboembolism: A meta-analysis of observational studies.","volume":"128","author":"M Pai","year":"2011","journal-title":"Thromb Res."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"1851-61","DOI":"10.1056\/NEJMoa0900241","article-title":"A randomized trial of rosuvastatin in the prevention of venous thromboembolism.","volume":"360","author":"R Glynn","year":"2009","journal-title":"N Engl J Med."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"1600-7","DOI":"10.1161\/CIRCULATIONAHA.120.046397","article-title":"The Effect of PCSK9 (Proprotein Convertase Subtilisin\/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism.","volume":"141","author":"N Marston","year":"2020","journal-title":"Circulation."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1038\/s41598-018-20425-x","article-title":"PCSK9 induces a pro-inflammatory response in macrophages.","volume":"8","author":"C Ricci","year":"2018","journal-title":"Sci Rep."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"1584-93","DOI":"10.1093\/eurheartj\/ehx002","article-title":"PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia.","volume":"38","author":"S Bernelot Moens","year":"2017","journal-title":"Eur Heart J."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"331-8","DOI":"10.1161\/ATVBAHA.118.312130","article-title":"Intrinsic Pathway of Coagulation and Thrombosis.","volume":"39","author":"S Grover","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"232-40","DOI":"10.1056\/NEJMoa1405760","article-title":"Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis.","volume":"372","author":"H B\u00fcller","year":"2015","journal-title":"N Engl J Med."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"130-9","DOI":"10.1001\/jama.2019.20687","article-title":"Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.","volume":"323","author":"J Weitz","year":"2020","journal-title":"JAMA."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"1724-38","DOI":"10.1161\/ATVBAHA.119.312463","article-title":"Neutrophil Extracellular Traps: Villains and Targets in Arterial, Venous, and Cancer-Associated Thrombosis.","volume":"39","author":"C Th\u00e5lin","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"147-54","DOI":"10.1182\/blood-2016-09-692996","article-title":"Emerging anticoagulant strategies.","volume":"129","author":"J Fredenburgh","year":"2017","journal-title":"Blood."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"1143-56","DOI":"10.1016\/j.cell.2009.11.001","article-title":"Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo.","volume":"139","author":"F M\u00fcller","year":"2009","journal-title":"Cell."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"1052-62","DOI":"10.1161\/ATVBAHA.118.310731","article-title":"Platelets Drive Thrombus Propagation in a Hematocrit and Glycoprotein VI\u2013Dependent Manner in an In Vitro Venous Thrombosis Model.","volume":"38","author":"M Lehmann","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"819-35","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo.","volume":"209","author":"K von Br\u00fchl M-L, Stark","year":"2012","journal-title":"J Exp Med."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"415-25","DOI":"10.1016\/j.phrs.2016.04.001","article-title":"Role of thromboxane-dependent platelet activation in venous thrombosis: Aspirin effects in mouse model.","volume":"107","author":"E Tarantino","year":"2016","journal-title":"Pharmacol Res."},{"key":"ref-43","doi-asserted-by":"crossref","first-page":"2281-6","DOI":"10.1182\/blood.V80.9.2281.bloodjournal8092281","article-title":"Importance of platelets in experimental venous thrombosis in the rat.","volume":"80","author":"J Herbert","year":"1992","journal-title":"Blood."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"1467-71","DOI":"10.1016\/j.jacc.2004.12.075","article-title":"Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism.","volume":"45","author":"J Chirinos","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"1062-71","DOI":"10.1161\/CIRCULATIONAHA.114.008828","article-title":"Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.","volume":"130","author":"J Simes","year":"2014","journal-title":"Circulation."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"27494-503","DOI":"10.1074\/jbc.M114.588640","article-title":"Reduced plasminogen binding and delayed activation render \u03b3'-fibrin more resistant to lysis than \u03b3A-fibrin.","volume":"289","author":"P Kim","year":"2014","journal-title":"J Biol Chem."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"3590-600","DOI":"10.1172\/JCI75386","article-title":"Factor XIII activity mediates red blood cell retention in venous thrombi.","volume":"124","author":"M Aleman","year":"2014","journal-title":"J Clin Invest."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"992-9","DOI":"10.1055\/s-0039-1685141","article-title":"Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi.","volume":"119","author":"S Shaya","year":"2019","journal-title":"Thromb Haemost."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"387-91","DOI":"10.1161\/ATVBAHA.108.162289","article-title":"Mechanisms of venous thrombosis and resolution.","volume":"28","author":"T Wakefield","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"2270-3","DOI":"10.1111\/jth.13805","article-title":"Disease prevalence dependent failure rate in diagnostic management studies on suspected deep vein thrombosis: communication from the SSC of the ISTH.","volume":"15","author":"C Dronkers","year":"2017","journal-title":"J Thromb Haemost."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"1040-3","DOI":"10.1111\/jth.13654","article-title":"Towards a tailored diagnostic standard for future diagnostic studies in pulmonary embolism: communication from the SSC of the ISTH.","volume":"15","author":"C Dronkers","year":"2017","journal-title":"J Thromb Haemost."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"1326-30","DOI":"10.1016\/s0140-6736(95)92535-x","article-title":"Accuracy of clinical assessment of deep-vein thrombosis.","volume":"345","author":"P Wells","year":"1995","journal-title":"Lancet."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"1795-8","DOI":"10.1016\/S0140-6736(97)08140-3","article-title":"Value of assessment of pretest probability of deep-vein thrombosis in clinical management.","volume":"350","author":"P Wells","year":"1997","journal-title":"Lancet."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"1227-35","DOI":"10.1056\/NEJMoa023153","article-title":"Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.","volume":"349","author":"P Wells","year":"2003","journal-title":"N Engl J Med."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"1247-55","DOI":"10.1111\/j.1538-7836.2004.00790.x","article-title":"Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism.","volume":"2","author":"J Kline","year":"2004","journal-title":"J Thromb Haemost."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"772-80","DOI":"10.1111\/j.1538-7836.2008.02944.x","article-title":"Prospective multicenter evaluation of the pulmonary embolism rule-out criteria.","volume":"6","author":"J Kline","year":"2008","journal-title":"J Thromb Haemost."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"1117-24","DOI":"10.1001\/jama.2014.2135","article-title":"Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study.","volume":"311","author":"M Righini","year":"2014","journal-title":"JAMA."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"93-100","DOI":"10.7326\/0003-4819-158-2-201301150-00003","article-title":"Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial.","volume":"158","author":"L Linkins","year":"2013","journal-title":"Ann Intern Med."},{"key":"ref-59","doi-asserted-by":"publisher","first-page":"2125-34","DOI":"10.1056\/NEJMoa1909159","article-title":"Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability.","volume":"381","author":"C Kearon","year":"2019","journal-title":"N Engl J Med."},{"key":"ref-60","doi-asserted-by":"publisher","first-page":"701-6","DOI":"10.1136\/emermed-2012-201730","article-title":"Pulmonary embolism rule-out criteria (PERC) in pulmonary embolism--revisited: a systematic review and meta-analysis.","volume":"30","author":"B Singh","year":"2013","journal-title":"Emerg Med J."},{"key":"ref-61","doi-asserted-by":"publisher","first-page":"289-96","DOI":"10.1111\/bjh.15780","article-title":"The use of artificial neural network analysis can improve the risk-stratification of patients presenting with suspected deep vein thrombosis.","volume":"185","author":"J Willan","year":"2019","journal-title":"Br J Haematol."},{"key":"ref-62","doi-asserted-by":"publisher","first-page":"289-97","DOI":"10.1016\/S0140-6736(17)30885-1","article-title":"Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study.","volume":"390","author":"T van der Hulle","year":"2017","journal-title":"Lancet."},{"key":"ref-63","doi-asserted-by":"publisher","first-page":"1139-49","DOI":"10.1056\/NEJMoa1813865","article-title":"Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism.","volume":"380","author":"L van der Pol","year":"2019","journal-title":"N Engl J Med."},{"key":"ref-64","doi-asserted-by":"publisher","first-page":"451-7","DOI":"10.7326\/M13-2056","article-title":"Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study.","volume":"160","author":"A Kleinjan","year":"2014","journal-title":"Ann Intern Med."},{"key":"ref-65","doi-asserted-by":"publisher","first-page":"59-62","DOI":"10.1016\/j.thromres.2016.10.019","article-title":"A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients.","volume":"148","author":"N van Es","year":"2016","journal-title":"Thromb Res."},{"key":"ref-66","doi-asserted-by":"publisher","first-page":"3226-56","DOI":"10.1182\/bloodadvances.2018024828","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism.","volume":"2","author":"W Lim","year":"2018","journal-title":"Blood Adv."},{"key":"ref-67","doi-asserted-by":"publisher","first-page":"1044-52","DOI":"10.1161\/CIRCULATIONAHA.114.008902","article-title":"18F-fluorodeoxyglucose positron emission tomography\/computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus.","volume":"130","author":"T Hara","year":"2014","journal-title":"Circulation."},{"key":"ref-68","doi-asserted-by":"publisher","first-page":"e530","DOI":"10.1161\/CIRCULATIONAHA.114.013786","article-title":"Letter by Klok et al Regarding Article, \"18F-Fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography Enables the Detection of Recurrent Same-Site Deep Vein Thrombosis by Illuminating Recently Formed, Neutrophil-Rich Thrombus\".","volume":"131","author":"F Klok","year":"2015","journal-title":"Circulation."},{"key":"ref-69","doi-asserted-by":"publisher","first-page":"e37-e44","DOI":"10.1055\/s-0039-1678683","article-title":"Diagnosing Recurrent DVT of the Leg by Two Different Non-Contrast-Enhanced Magnetic Resonance Direct Thrombus Imaging Techniques: A Pilot Study.","volume":"3","author":"C Dronkers","year":"2019","journal-title":"TH Open."},{"key":"ref-70","doi-asserted-by":"publisher","first-page":"623-7","DOI":"10.1182\/blood-2014-04-566380","article-title":"Magnetic resonance direct thrombus imaging differentiates acute recurrent ipsilateral deep vein thrombosis from residual thrombosis.","volume":"124","author":"M Tan","year":"2014","journal-title":"Blood."},{"key":"ref-71","doi-asserted-by":"publisher","first-page":"e3675","DOI":"10.1136\/bmj.e3675","article-title":"Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons.","volume":"344","author":"A G\u00f3mez-Outes","year":"2012","journal-title":"BMJ."},{"key":"ref-72","doi-asserted-by":"publisher","first-page":"3898-944","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.","volume":"3","author":"D Anderson","year":"2019","journal-title":"Blood Adv."},{"key":"ref-73","doi-asserted-by":"publisher","first-page":"668-74","DOI":"10.1055\/s-0039-1677732","article-title":"Reduction in Mortality following Elective Major Hip and Knee Surgery: A Systematic Review and Meta-Analysis.","volume":"119","author":"K Xu","year":"2019","journal-title":"Thromb Haemost."},{"key":"ref-74","doi-asserted-by":"publisher","first-page":"699-707","DOI":"10.1056\/NEJMoa1712746","article-title":"Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty.","volume":"378","author":"D Anderson","year":"2018","journal-title":"N Engl J Med."},{"key":"ref-75","doi-asserted-by":"publisher","first-page":"3198-225","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.","volume":"2","author":"H Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv."},{"key":"ref-76","doi-asserted-by":"publisher","first-page":"1118-27","DOI":"10.1056\/NEJMoa1805090","article-title":"Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.","volume":"379","author":"A Spyropoulos","year":"2018","journal-title":"N Engl J Med."},{"key":"ref-77","doi-asserted-by":"publisher","first-page":"720-8","DOI":"10.1056\/NEJMoa1814630","article-title":"Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.","volume":"380","author":"A Khorana","year":"2019","journal-title":"N Engl J Med."},{"key":"ref-78","doi-asserted-by":"publisher","first-page":"711-9","DOI":"10.1056\/NEJMoa1814468","article-title":"Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.","volume":"380","author":"M Carrier","year":"2019","journal-title":"N Engl J Med."},{"key":"ref-79","doi-asserted-by":"publisher","first-page":"496-520","DOI":"10.1200\/JCO.19.01461","article-title":"Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.","volume":"38","author":"N Key","year":"2020","journal-title":"J Clin Oncol."},{"key":"ref-80","doi-asserted-by":"publisher","first-page":"1968-75","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.","volume":"124","author":"N van Es","year":"2014","journal-title":"Blood."},{"key":"ref-81","doi-asserted-by":"publisher","first-page":"709-18","DOI":"10.1056\/NEJMoa1113697","article-title":"Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.","volume":"368","author":"S Schulman","year":"2013","journal-title":"N Engl J Med."},{"key":"ref-82","doi-asserted-by":"publisher","first-page":"699-708","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism.","volume":"368","author":"G Agnelli","year":"2013","journal-title":"N Engl J Med."},{"key":"ref-83","doi-asserted-by":"publisher","first-page":"2499-510","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism.","volume":"363","author":"R Bauersachs","year":"2010","journal-title":"N Engl J Med."},{"key":"ref-84","doi-asserted-by":"publisher","first-page":"e228-e236","DOI":"10.1016\/S2352-3026(16)00023-5","article-title":"Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.","volume":"3","author":"G Raskob","year":"2016","journal-title":"Lancet Haematol."},{"key":"ref-85","doi-asserted-by":"publisher","first-page":"1288-95","DOI":"10.1111\/jth.14156","article-title":"Reduced-dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta-analysis.","volume":"16","author":"L Vasanthamohan","year":"2018","journal-title":"J Thromb Haemost."},{"key":"ref-86","doi-asserted-by":"publisher","first-page":"631-9","DOI":"10.1056\/NEJMoa035422","article-title":"Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.","volume":"349","author":"C Kearon","year":"2003","journal-title":"N Engl J Med."},{"key":"ref-87","doi-asserted-by":"publisher","first-page":"1211-22","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.","volume":"376","author":"J Weitz","year":"2017","journal-title":"N Engl J Med."},{"key":"ref-88","doi-asserted-by":"publisher","first-page":"689-94","DOI":"10.1055\/s-0039-1679906","article-title":"Long-Term Management of Venous Thromboembolism: Lessons from EINSTEIN CHOICE and Other Extension Trials.","volume":"119","author":"J Weitz","year":"2019","journal-title":"Thromb Haemost."},{"key":"ref-89","doi-asserted-by":"publisher","first-page":"615-24","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.","volume":"378","author":"G Raskob","year":"2018","journal-title":"N Engl J Med."},{"key":"ref-90","doi-asserted-by":"publisher","first-page":"2017-23","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).","volume":"36","author":"A Young","year":"2018","journal-title":"JCO."},{"key":"ref-91","doi-asserted-by":"publisher","first-page":"411-21","DOI":"10.1111\/jth.14662","article-title":"Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial.","volume":"18","author":"R McBane","year":"2020","journal-title":"J Thromb Haemost."},{"key":"ref-92","doi-asserted-by":"publisher","first-page":"1599-607","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.","volume":"382","author":"G Agnelli","year":"2020","journal-title":"N Engl J Med."},{"key":"ref-93","doi-asserted-by":"publisher","first-page":"1891-4","DOI":"10.1111\/jth.14219","article-title":"Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH.","volume":"16","author":"A Khorana","year":"2018","journal-title":"J Thromb Haemost."},{"key":"ref-94","doi-asserted-by":"publisher","first-page":"1365-71","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.","volume":"132","author":"V Pengo","year":"2018","journal-title":"Blood."},{"key":"ref-95","doi-asserted-by":"publisher","first-page":"685-94","DOI":"10.7326\/M19-0291","article-title":"Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.","volume":"171","author":"J Ordi-Ros","year":"2019","journal-title":"Ann Intern Med."},{"key":"ref-96","doi-asserted-by":"publisher","first-page":"195-7","DOI":"10.1111\/jth.13535","article-title":"Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH: reply.","volume":"15","author":"H Cohen","year":"2017","journal-title":"J Thromb Haemost."},{"key":"ref-97","doi-asserted-by":"publisher","first-page":"j4323","DOI":"10.1136\/bmj.j4323","article-title":"Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study.","volume":"359","author":"M Jun","year":"2017","journal-title":"BMJ."},{"key":"ref-98","doi-asserted-by":"publisher","first-page":"426-36","DOI":"10.1161\/CIRCRESAHA.118.313155","article-title":"Antithrombotic Agents.","volume":"124","author":"N Chan","year":"2019","journal-title":"Circ Res."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/9-1206\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-1206\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-1206\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T07:55:10Z","timestamp":1602057310000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/9-1206\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":98,"URL":"https:\/\/doi.org\/10.12688\/f1000research.27115.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.29952.r72119","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.29952.r72118","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/9-1206\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.29952.r72118, Henri Spronk, Department of Internal Medicine, (CARIM), Maastricht University Medical Center, Maastricht, The Netherlands, 06 Oct 2020, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/9-1206\/v1#referee-response-72118","order":0,"name":"referee-response-72118","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.29952.r72119, Peter Henke, Section of Vascular Surgery, Department of Surgery, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA, 06 Oct 2020, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/9-1206\/v1#referee-response-72119","order":1,"name":"referee-response-72119","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}